Novartis AG Recalls Some Cough And Cold Syrup In UK Due To Defect

Published: Dec 13, 2013

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Novartis (NOVN.VX) said on Friday it was recalling some batches of its Tixylix liquid cough and cold medicines for children because of a potential manufacturing defect that could result in small pieces of plastic being found in the bottles. Although no plastic has been discovered so far and the risk is "very low", the drugmaker said it was recalling certain batches from consumers, retail customers and wholesalers.

Help employers find you! Check out all the jobs and post your resume.

Back to news